BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15745832)

  • 1. Further studies on ethenyl and ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of a subnanomolar Src kinase inhibitor.
    Barrios Sosa AC; Boschelli DH; Wu B; Wang Y; Golas JM
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1743-7. PubMed ID: 15745832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of SKS-927.
    Boschelli DH; Barrios Sosa AC; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1358-61. PubMed ID: 17188862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and inhibition of Src kinase activity by 7-ethenyl and 7-ethynyl-4-anilino-3-quinolinecarbonitriles.
    Barrios Sosa AC; Boschelli DH; Ye F; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2004 May; 14(9):2155-8. PubMed ID: 15080999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-(aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: addition of water solubilizing groups.
    Wu B; Barrios Sosa AC; Boschelli DH; Boschelli F; Honores EE; Golas JM; Powell DW; Wang YD
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3993-7. PubMed ID: 16735116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors.
    Boschelli DH; Wang D; Wang Y; Wu B; Honores EE; Barrios Sosa AC; Chaudhary I; Golas J; Lucas J; Boschelli F
    Bioorg Med Chem Lett; 2010 May; 20(9):2924-7. PubMed ID: 20363128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.
    Sun M; Zheng Y; Wei H; Chen J; Ji M
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1109-16. PubMed ID: 19555174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
    Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.
    Boschelli DH; Wang YD; Johnson S; Wu B; Ye F; Barrios Sosa AC; Golas JM; Boschelli F
    J Med Chem; 2004 Mar; 47(7):1599-601. PubMed ID: 15027848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile preparation of new 4-phenylamino-3-quinolinecarbonitrile Src kinase inhibitors via 7-fluoro intermediates: identification of potent 7-amino analogs.
    Boschelli DH; Wu B; Ye F; Durutlic H; Golas JM; Lucas J; Boschelli F
    Bioorg Med Chem; 2008 Jan; 16(1):405-12. PubMed ID: 17905586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Src kinase inhibitory and anticancer activities of 1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols.
    Sharma D; Sharma RK; Bhatia S; Tiwari R; Mandal D; Lehmann J; Parang K; Olsen CE; Parmar VS; Prasad AK
    Biochimie; 2010 Sep; 92(9):1164-72. PubMed ID: 20447438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
    Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles.
    Boschelli DH; Wang YD; Ye F; Wu B; Zhang N; Dutia M; Powell DW; Wissner A; Arndt K; Weber JM; Boschelli F
    J Med Chem; 2001 Mar; 44(5):822-33. PubMed ID: 11262092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity.
    Boschelli DH; Ye F; Wang YD; Dutia M; Johnson SL; Wu B; Miller K; Powell DW; Yaczko D; Young M; Tischler M; Arndt K; Discafani C; Etienne C; Gibbons J; Grod J; Lucas J; Weber JM; Boschelli F
    J Med Chem; 2001 Nov; 44(23):3965-77. PubMed ID: 11689083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles.
    Boschelli DH; Wu B; Barrios Sosa AC; Durutlic H; Chen JJ; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2005 Jun; 48(11):3891-902. PubMed ID: 15916442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical studies of QSAR and molecular design on a novel series of ethynyl-3-quinolinecarbonitriles as SRC inhibitors.
    Fang DQ; Wu WJ; Zhang R; Zeng GH; Zheng KC
    Chem Biol Drug Des; 2012 Jul; 80(1):134-47. PubMed ID: 22429605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitriles.
    Boschelli DH; Wang DY; Ye F; Yamashita A; Zhang N; Powell D; Weber J; Boschelli F
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2011-4. PubMed ID: 12113830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the effect of varying the 4-anilino and 7-alkoxy groups of 3-quinolinecarbonitriles on the inhibition of Src kinase activity.
    Boschelli DH; Ye F; Wu B; Wang YD; Barrios Sosa AC; Yaczko D; Powell D; Golas JM; Lucas J; Boschelli F
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3797-800. PubMed ID: 14552782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles.
    Boschelli DH; Wu B; Barrios Sosa AC; Chen JJ; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4681-4. PubMed ID: 16125383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.